Ƶ

Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis

— News, features, and commentary about cancer-related issues

Ƶ MedicalToday
Onco Break over a computer rendering of a cancer cell.

If projected changes in population growth and aging hold, a "tidal wave" of cancer cases could increase the over the next 25 years. (CA: A Cancer Journal for Clinicians)

A cancer offers services and support for patients who are carriers of BRCA mutations. (Cedars-Sinai Medical Center)

A might also have a link to some colon cancers. (NIH)

The American Lung Association has launched a public education campaign to increase awareness and understanding about .

More than 20% of Americans participate in . (Fred Hutchinson Cancer Center, Journal of Clinical Oncology)

The FDA expanded the approval of idecabtagene vicleucel (Abecma) in relapsed or refractory multiple myeloma; the CAR T-cell therapy can now be used to treat triple-class exposed patients after two prior lines of treatment, .

AstraZeneca announced that a phase III trial showed that durvalumab (Imfinzi) significantly improved overall survival and progression-free survival (PFS) in that had not progressed after concurrent chemoradiotherapy.

Gritstone bio announced that a phase II study of its improved PFS as initial therapy for metastatic microsatellite stable colorectal cancer.

Researchers "do not see an obvious path forward" for the targeted drug tomivosertib, which did not meet the prespecified endpoint of improved PFS in when added to pembrolizumab (Keytruda), eFFECTOR Therapeutics announced.

Just when you thought you had sorted out the health issues surrounding regular coffee, health advocacy groups have set their sights on a ban of a . (CNN)

An oncologist offers cautionary tales about . (The Guardian)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined Ƶ in 2007.